To improve the quality of healthcare by providing innovative discovery, development and manufacturing solutions to enable superior therapeutic options for patients
To be the preferred provider of specialist services and proprietary technologies to enable the development and commercialisation of better biopharmaceuticals products
To actively engage with innovators to accelerate the development process for innovative and differentiated products
To sustain a strong reputation as an innovator in the field of biopharmaceutical development
Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. The Group offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals.About Us
Contact Investor Relations
Our Latest News and Events
Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.
Abzena and Telix sign strategic manufacturing and bioconjugation agreement
Webinar: Considerations in the Discovery, Development and Manufacture of Antibody Drug Conjugates
28 June 2018
Funding update: Seeking to monetise royalty-bearing ABZENA Inside products
10 July 2018